DAVID MCLEOD HERRINGTON, MD
Osteopathic Medicine at Medical Center Blvd, Winston Salem, NC

License number
North Carolina 39151
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
Medical Center Blvd, Winston Salem, NC 27157
Phone
(336) 716-2255

Personal information

See more information about DAVID MCLEOD HERRINGTON at radaris.com
Name
Address
Phone
David Herrington, age 67
5225 Huntscroft Ct, Winston Salem, NC 27106
(336) 512-9894
David Herrington
37 Colonial Pl, Asheville, NC 28804
(828) 281-1823

Professional information

See more information about DAVID MCLEOD HERRINGTON at trustoria.com
David M Herrington Photo 1
Dr. David M Herrington, Winston Salem NC - MD (Doctor of Medicine)

Dr. David M Herrington, Winston Salem NC - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
(336) 716-2011 (Phone)
Wake Forest Baptist Health
Medical Center Blvd, Winston Salem 27157
(336) 716-6674 (Phone)
Procedures:
Cardiac Imaging, Chest CT (incl. Heart and Lungs)
Conditions:
Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypotension, Mitral Valve Disease, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1989, Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Health
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Medical Center
Medical Center Blvd, Winston Salem 27157
Education:
Medical School
University of North Carolina At Chapel Hill
Graduated: 1983
The Johns Hopkins Hospital


David Mcleod Herrington Photo 2
David McLeod Herrington, Winston Salem NC

David McLeod Herrington, Winston Salem NC

Specialties:
Cardiologist
Address:
Medical Center Blvd, Winston Salem, NC 27157
Education:
University of North Carolina, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)


David Herrington Photo 3
Mutations In The Macrophage Scavenger Receptor 1 Gene Alter Risk Of Prostate Cancer, Asthma, And Cardiovascular Disease

Mutations In The Macrophage Scavenger Receptor 1 Gene Alter Risk Of Prostate Cancer, Asthma, And Cardiovascular Disease

US Patent:
7579147, Aug 25, 2009
Filed:
Apr 30, 2003
Appl. No.:
10/426262
Inventors:
Jianfeng Xu - Clemmons NC, US
Deborah Meyers - Mocksville NC, US
Sigun Zheng - Clemmons NC, US
Patrick C. Walsh - Hunt Valley MD, US
William B. Isaacs - Glyndon MD, US
Eugene Bleecker - Winston-Salem NC, US
David Herrington - Winston Salem NC, US
Assignee:
Wake Forest University Health Sciences - Winston-Salem NC
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention discloses methods of screening a subject for increased likelihood or risk of certain diseases or disorders. This method comprises detecting the presence or absence of at least one mutation in the MSR1 gene wherein the presence or absence of such mutation indicates an increased risk for certain diseases, such as cancer asthma and/or cardiovascular diseases.


David Herrington Photo 4
Mutations In The Macrophage Scavenger Receptor 1 Gene Alter Risk Of Prostate Cancer, Asthma, And Cardiovascular Disease

Mutations In The Macrophage Scavenger Receptor 1 Gene Alter Risk Of Prostate Cancer, Asthma, And Cardiovascular Disease

US Patent:
8192928, Jun 5, 2012
Filed:
Jul 16, 2009
Appl. No.:
12/504034
Inventors:
Jianfeng Xu - Clemmons NC, US
Deborah Meyers - Mocksville NC, US
Sigun Zheng - Clemmons NC, US
Patrick C. Walsh - Hunt Valley MD, US
William B. Isaacs - Glyndon MD, US
Eugene Bleecker - Winston-Salem NC, US
David Herrington - Winston Salem NC, US
Assignee:
Wake Forest University Health Sciences - Winston-Salem NC
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention discloses methods of screening a subject for increased likelihood or risk of certain diseases or disorders. This method comprises detecting the presence or absence of at least one mutation in the MSR1 gene wherein the presence or absence of such mutation indicates an increased risk for certain diseases, such as cancer asthma and/or cardiovascular diseases.


David Herrington Photo 5
Ultrasound Apparatus And Method For Tissue Characterization

Ultrasound Apparatus And Method For Tissue Characterization

US Patent:
6264609, Jul 24, 2001
Filed:
Sep 15, 1999
Appl. No.:
9/396153
Inventors:
David M. Herrington - Winston-Salem NC
Liexiang Fan - Winston-Salem NC
Peter Santago - Clemmons NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
A61B 800
US Classification:
600443
Abstract:
The present invention relates generally to a medical device, and more particularly to ultrasound apparatus and methods for the identification and characterization of tissues, tissue transitions and tissue constituent structures.


David Mc Leod Herrington Photo 6
David Mc Leod Herrington, Winston-Salem NC

David Mc Leod Herrington, Winston-Salem NC

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
Wake Forest Univ Baptist Med Cntr
Medical Center Blvd, Winston-Salem, NC
Education:
University of North Carolina (1983)


David Herrington Photo 7
Genetic Polymorphisms Of Estrogen Receptor Alpha Associated With Favorable Response To Hormone Replacement Therapy

Genetic Polymorphisms Of Estrogen Receptor Alpha Associated With Favorable Response To Hormone Replacement Therapy

US Patent:
6828103, Dec 7, 2004
Filed:
Feb 22, 2002
Appl. No.:
10/081563
Inventors:
David M. Herrington - Winston-Salem NC
Timothy D. Howard - Clemmons NC
Gregory A. Hawkins - High Point NC
Deborah A. Meyers - Mocksville NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 436 94, 536 2351, 536 2431
Abstract:
A method of screening a subject for increased likelihood of having a favorable response to estrogen replacement therapy comprises detecting the presence of the rare form of at least one estrogen receptor alpha polymorphism in the subject, the presence of the estrogen receptor alpha polymorphism indicating the subject is more likely to have a favorable response to estrogen replacement therapy (e. g. , with respect to cardiovascular health, heart disease, and/or HDL levels).